Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMC Cancer|November 18, 2024
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinomaHaohao Lu, Bin Liang, Chuansheng Zheng, et al.
Medicine|October 6, 2023
Efficacy and safety analysis of dexamethasone + palonosetron in prevention of post-embolization syndrome after D-TACE: A retrospective studyHaohao Lu, Chuansheng Zheng, Bin Liang, et al.
BMC Cancer|September 2, 2024
Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinomaHaohao Lu, Bin Liang, Xiangwen Xia, et al.
BMC Gastroenterology|November 19, 2025
Efficacy and safety analysis of D-TACE combined with lenvatinib in the treatment of hepatocellular carcinoma refractory to C-TACEHaohao Lu, Bin Liang, Chuansheng Zheng, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 22, 2024
Efficacy Analysis of PTCD + TACE vs PTCD + Apatinib in the Treatment of HCC with Obstructive Jaundice: A Retrospective StudyHaohao Lu, Bin Liang, Xiangwen Xia, et al.
Current Radiopharmaceuticals|December 1, 2023
Analysis of the Efficacy and Safety of Palonosetron Hydrochloride in Preventing Nausea And Vomiting After TACE: A Retrospective AnalysisHaohao Lu, Chuansheng Zheng, Bin Liang, et al.
BMC Cancer|March 14, 2023
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinomaHaohao Lu, Chuansheng Zheng, Bin Xiong, et al.
BMC Gastroenterology|November 19, 2022
Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegalyHaohao Lu, Chuansheng Zheng, Bin Xiong, et al.
BMC Cancer|October 25, 2023
Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective studyHaohao Lu, Bin Liang, Xiangwen Xia, et al.
BMC Cancer|June 9, 2026
Efficacy and safety analysis of TACE combined with lenvatinib and icaritin in unresectable hepatocellular carcinoma with poor performance statusHaohao Lu, Bin Liang, Chuansheng Zheng, et al.
Pageof 4